Gå direkt till innehåll

Kontakter

  • Per Öhlén

    Per Öhlén

    Presskontakt VD Sanofi Sverige & General Manager Sanofi Vaccines North Europe
  • DATA PRESENTED AT AMERICAN DIABETES ASSOCIATION SCIENTIFIC SESSIONS SUPPORT EXUBERA EFFICACY AND SAFETY PROFILE IN TYPE 1 A AND TYPE 2 DIABETES
    DATA PRESENTED AT AMERICAN DIABETES ASSOCIATION SCIENTIFIC SESSIONS SUPPORT EXUBERA EFFICACY AND SAFETY PROFILE IN TYPE 1 A AND TYPE 2 DIABETES
    Licens:
    Medieanvändning
    Filformat:
    .pdf
    Ladda ner